IRIS Accounts Production v26.3.0.614 11905256 director 1.4.25 31.3.26 31.3.26 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119052562025-03-31119052562026-03-31119052562025-04-012026-03-31119052562024-03-31119052562024-04-012025-03-31119052562025-03-3111905256ns15:EnglandWales2025-04-012026-03-3111905256ns14:PoundSterling2025-04-012026-03-3111905256ns10:Director12025-04-012026-03-3111905256ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3111905256ns10:SmallEntities2025-04-012026-03-3111905256ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3111905256ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3111905256ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3111905256ns10:FullAccounts2025-04-012026-03-311190525612025-04-012026-03-3111905256ns10:RegisteredOffice2025-04-012026-03-3111905256ns5:CurrentFinancialInstruments2026-03-3111905256ns5:CurrentFinancialInstruments2025-03-3111905256ns5:Non-currentFinancialInstruments2026-03-3111905256ns5:Non-currentFinancialInstruments2025-03-3111905256ns5:ShareCapital2026-03-3111905256ns5:ShareCapital2025-03-3111905256ns5:RetainedEarningsAccumulatedLosses2026-03-3111905256ns5:RetainedEarningsAccumulatedLosses2025-03-3111905256ns5:NetGoodwill2025-04-012026-03-3111905256ns5:LandBuildings2025-04-012026-03-3111905256ns5:PlantMachinery2025-04-012026-03-3111905256ns5:NetGoodwill2025-03-3111905256ns5:NetGoodwill2026-03-3111905256ns5:NetGoodwill2025-03-3111905256ns5:LandBuildings2025-03-3111905256ns5:PlantMachinery2025-03-3111905256ns5:LandBuildings2026-03-3111905256ns5:PlantMachinery2026-03-3111905256ns5:LandBuildings2025-03-3111905256ns5:PlantMachinery2025-03-3111905256ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2025-03-3111905256ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2025-04-012026-03-3111905256ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2026-03-3111905256ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2025-03-3111905256ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3111905256ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3111905256ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2026-03-3111905256ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-03-3111905256ns5:HirePurchaseContractsns5:BetweenOneFiveYears2026-03-3111905256ns5:HirePurchaseContractsns5:BetweenOneFiveYears2025-03-3111905256ns5:HirePurchaseContracts2026-03-3111905256ns5:HirePurchaseContracts2025-03-3111905256ns5:BetweenOneFiveYears2026-03-3111905256ns5:BetweenOneFiveYears2025-03-3111905256ns5:MoreThanFiveYears2026-03-3111905256ns5:MoreThanFiveYears2025-03-3111905256ns5:AllPeriods2026-03-3111905256ns5:AllPeriods2025-03-3111905256ns5:Secured2026-03-3111905256ns5:Secured2025-03-3111905256ns5:DeferredTaxation2025-03-3111905256ns5:DeferredTaxation2025-04-012026-03-3111905256ns5:DeferredTaxation2026-03-31
REGISTERED NUMBER: 11905256 (England and Wales)















A2 HEALTH LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026






A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A2 HEALTH LTD

COMPANY INFORMATION
for the year ended 31 March 2026







DIRECTOR: J T Vadodaria





REGISTERED OFFICE: Swillington Pharmacy Church Lane
Swillington
Leeds
LS26 8DY





REGISTERED NUMBER: 11905256 (England and Wales)





ACCOUNTANTS: SMH Sheards
Vernon House
40 New North Road
Huddersfield
West Yorkshire
HD1 5LS

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

BALANCE SHEET
31 March 2026

2026 2025
Notes £    £   
FIXED ASSETS
Intangible assets 4 1,019,403 1,019,403
Tangible assets 5 317,432 342,530
1,336,835 1,361,933

CURRENT ASSETS
Stocks 34,261 45,347
Debtors 6 223,779 278,496
Cash at bank and in hand 40,723 79,466
298,763 403,309
CREDITORS
Amounts falling due within one year 7 (238,972 ) (277,356 )
NET CURRENT ASSETS 59,791 125,953
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,396,626

1,487,886

CREDITORS
Amounts falling due after more than one
year

8

(936,768

)

(1,048,222

)

PROVISIONS FOR LIABILITIES 11 (25,691 ) (30,799 )
NET ASSETS 434,167 408,865

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 434,067 408,765
SHAREHOLDERS' FUNDS 434,167 408,865

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

BALANCE SHEET - continued
31 March 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 October 2026 and were signed by:





J T Vadodaria - Director


A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2026


1. STATUTORY INFORMATION

A2 Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the sale of goods is recognised when the significant risk and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Goodwill
Goodwill is considered to have an indefinite life that can be demonstrated, and the value of the goodwill can be readily measured. The dispensing chemist industry, in which the company operates, has high market entry
barriers due to the nature of licence agreements with local health authorities and the limited number available in the marketplace. The value of the business can be ascertained by reference to the current value of goodwill which is payable in the market based on a price per £ in relation to the levels of turnover for each individual pharmacy. The director reviews the value of goodwill on an annual basis and considers it to be worth in excess of the net book value.

This is a departure from Companies Act 2006 which states that goodwill must be amortised, but the director has departed from these requirements for the purpose of showing a true and fair view.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Land and buildings - 2% on cost
Plant and machinery etc - 33% on cost, 25% on cost and 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2026


2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Basic financial assets, which include trade and other debtors, amounts owed by group undertakings and cash and bank balances, are initially measured at transaction price including transaction costs.

Financial assets, other than those held at fair value through profit or loss, are assessed for indicators of impairment at each balance sheet date, with any impairment losses being recognised in profit or loss. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed in profit or loss.

Financial liabilities are classified depending on the substance of the contractual arrangements entered into.

Basic financial liabilities, including trade and other creditors, bank loans, finance leases, accruals and amounts owed to group undertakings, are initially recognised at transaction price.

Debt instruments are subsequently measured at amortised cost using the effective interest method.

Financial assets and liabilities are derecognised when the company's contractual obligations are settled, cancelled or they expire.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2026


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Grants
Grant income is accounted for on an accruals basis, with the income matching the year in which the related expenditure is incurred.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2025 - 11 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2025
and 31 March 2026 1,059,196
AMORTISATION
At 1 April 2025
and 31 March 2026 39,793
NET BOOK VALUE
At 31 March 2026 1,019,403
At 31 March 2025 1,019,403

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2025
and 31 March 2026 233,335 152,822 386,157
DEPRECIATION
At 1 April 2025 14,000 29,627 43,627
Charge for year 4,667 20,431 25,098
At 31 March 2026 18,667 50,058 68,725
NET BOOK VALUE
At 31 March 2026 214,668 102,764 317,432
At 31 March 2025 219,335 123,195 342,530

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2026


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 April 2025
and 31 March 2026 120,639
DEPRECIATION
At 1 April 2025 16,282
Charge for year 16,282
At 31 March 2026 32,564
NET BOOK VALUE
At 31 March 2026 88,075
At 31 March 2025 104,357

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 148,974 134,689
Amounts owed by associates 38,111 104,358
Other debtors 36,694 39,449
223,779 278,496

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Bank loans and overdrafts 48,239 53,346
Hire purchase contracts (see note 9) 26,054 25,463
Trade creditors 87,401 168,731
Amounts owed to associates 41,435 -
Taxation and social security 28,452 18,851
Other creditors 7,391 10,965
238,972 277,356

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2026


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2026 2025
£    £   
Bank loans 876,532 925,008
Hire purchase contracts (see note 9) 60,236 86,290
Other creditors - 36,924
936,768 1,048,222

Amounts falling due in more than five years:

Repayable by instalments
Bank loans 670,564 730,055

9. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2026 2025
£    £   
Net obligations repayable:
Within one year 26,054 25,463
Between one and five years 60,236 86,290
86,290 111,753

Non-cancellable
operating leases
2026 2025
£    £   
Between one and five years 27,220 45,988
In more than five years 370,000 400,000
397,220 445,988

10. SECURED DEBTS

The following secured debts are included within creditors:

2026 2025
£    £   
Bank loans 924,771 978,354

The bank loan to acquire the business and property is secured over the property and by way of fixed and floating charge of the assets of the business, combined with an insurance policy over the life of the director.

Government backed loans are secured by way of government initiative.

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2026


11. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 25,691 30,799

Deferred
tax
£   
Balance at 1 April 2025 30,799
Provided during year (5,108 )
Balance at 31 March 2026 25,691

12. RELATED PARTY DISCLOSURES

At the year end, £Nil (2025: £36,924) was owed to some of the shareholders directly, or through a company in which a shareholder is also a shareholder.

Interest is being paid on the loans at commercial rate of interest.

At the year end, £3,324 (2025: £104,358) was owed by the company to companies that are under common control of the shareholders.